93 results about "Glass Syringe" patented technology

An improved guard for a medical cartridge, such as a unit dose pre-filled glass syringe, comprising a body for receiving the cartridge, and a shield slidably attached to the body which are pre-assembled and ready to receive a cartridge therein. The body has a mechanism on a proximal end thereof which holds the cartridge therein. The body and shield have cooperating detents and detent pockets which allow the shield to be directed distally, from an unguarded position in which the needle on the cartridge is uncovered for delivery of medication, to a guarded position in which the needle is permanently covered for disposal. The body may also include a substantially rectangular-shaped finger grip on its proximal end for receiving a similarly shaped proximal flange on the cartridge, whereby the cartridge is received in a predetermined orientation.

The invention relates to a method for preparing a nanofiber bracket material using levorotatory polylactic acid as matrix. The method comprises the following steps: dissolving the levorotatory polylactic acid as the matrix in a solution of dichloromethane and dimethyl formamide, and stirring and centrifuging the mixture to obtain an electrostatic spinning solution; placing a polylactic acid solution into a 5 milliliter glass syringe, and applying high voltage on the glass syringe; advancing the levorotatory polylactic acid solution in the glass syringe; preparing the mixed solution into a nanofiber material film through a electrostatic spinning technology; and modifying the nanofiber material film to obtain the nanofiber bracket material of which the fiber diameter is between 50 and 500 nanometers and the fiber porosity is more than 90 percent. The method solves the defects that a PLLA porous bracket still has too long degradation time, and degradation products can cause tissue inflammations easily and the like. The method has the advantages of flexible texture, better water permeability and air permeability, excellent tissue compatibility, controllable biodegradability, and no antigenicity.

A package has a rectangular parallelepiped container including vertical front and rear panel sections connected by a pair of vertical side panel sections, a top wall connected to the upper edge of the rear panel section and a bottom wall connected to the at least one of the lower edges of the vertical panels and a top cushion panel disposed beneath the top wall and rotatably connected to at least one upper edge of the side panel sections. A holder is disposed, in the container, for holding a plurality of glass syringes each of which is sealingly contained in a plastic bag.

A syringe, particularly preferred for use as a prefilled syringe, that has a retractable needle and is characterized by a liquid containment chamber of variable volume, the liquid containment chamber being further defined by surfaces made of glass or an elastomeric material, and not of plastic, and the syringe having no glass part directly contacting another glass part.

The present invention relates to a prefilled glass container, such as a prefilled glass syringe, comprising an aqueous botulinum toxin formulation. The aqueous botulinum toxin formulation in the prefilled container is stable at low to ambient temperature for a prolonged time period. Furthermore, the present invention relates to a kit comprising the botulinum toxin prefilled container, and to the use of the botulinum toxin prefilled container in therapeutic and cosmetic applications.

A package has a rectangular parallelepiped container including vertical front and rear panel sections connected by a pair of vertical side panel sections, a top wall connected to the upper edge of the rear panel section and a bottom wall connected to the at least one of the lower edges of the vertical panels and a top cushion panel disposed beneath the top wall and rotatably connected to at least one upper edge of the side panel sections. A holder is disposed, in the container, for holding a plurality of glass syringes each of which is sealingly contained in a plastic bag.

An injection device for delivery of a therapeutic agent is provided that includes a glass syringe with an integrally molded lug extending radially from the syringe and a guard slidably attached to the syringe. One set of detents on the guard and the lug of the syringe retain the guard in the retracted position. Another set of detents on the guard and the lug of the syringe retain the guard in the extended position. Another injection device for delivery of a therapeutic agent is provided that includes a glass syringe with an integrally molded disk that extends radially from the syringe and a guard slidably coupled to the syringe. One set of detents on the guard and the integrally molded disk of the syringe retain the guard in a retracted position. Another set of detents on the guard and the integrally molded disk retain the guard in an extended position.

The invention relates to a method for preparing a microencapsulated drink of a Nanguo pear liver-protecting anti-alcohol agent, which is particularly used for Nanguo pear fruit and provides a theoretical basis for quantification of ethanol and acetaldehyde dehydrogenase in Nanguo pear liver-protecting anti-alcohol drink production. The process of the method comprises: raw material selection, washing, block cutting, water-bath soakage, ice-bath grinding, ice-bath homogenization, one-hour 0 to 4 DEG C extraction, 15-minute 400-rpm centrifugation, freezing concentration, the preparation of enteric microencapsulates of mixed concentrates of the ethanol, the acetaldehyde dehydrogenase and the like and the preparation of the drink by blending according to required package. The preparation of enteric microencapsulates of the mixed concentrates of the ethanol, the acetaldehyde dehydrogenase and the like is implemented by the following steps: mixing a wet enzyme paste mixture and 10 percent gelatin and 5 percent xanthan gum in a volume ratio of 1:5.5; fully and uniformly mixing the materials; uniformly mixing the mixed materials with a certain amount of 2-percent sodium alga acid; injecting the mixed solution into cooled solution of CaCl2 by using a glass syringe with a No.4 syringe needle to perform emulsification for 10 minutes with a stirring speed or 400rpm to obtain colloid-calcium alginate double-layer gel beads; subjecting the colloid-calcium alginate double-layer gel beads to a film forming reaction with solution of chitosan for 30 minutes; removing unreacted chitosan by washing to obtain wet Nanguo pear-dehydrogenase combined microencapsulate gel beads; and placing the microencapsulated dehydrogenase microencapsulate gel beads in a regulation tank for regulating concentration according to an anti-alcohol ratio, adding a proper amount of sugar and other seasoning matters, homogenizing the mixture, and automatically filling and sealing the resulting product.

A connector mountable to a syringe barrel has a proximal barrel-engaging portion, a distal luer fitment portion, and a fluid aperture therethrough. The barrel-engaging portion of the connector includes an axial ledge configured to abut the axial distal edge of a glass syringe barrel. The connector facilitates mounting a luer assembly to the barrel. The luer assembly may be a tip cap, a luer needle assembly, or a luer needle-less assembly, having a complementary luer fitment for connection to the luer fitment portion of the connector. The connector and syringe may further include an immobile, compressible needle seal. The needle seal is adjacent to or engageable with the barrel-engaging portion of the connector.

The invention provides a pneumatic syringe. The pneumatic syringe comprises a plurality of glass syringe bodies and is characterized in that the end face of one end of each syringe body is provided with a liquid outlet, the other end face of each syringe body is provided with an air inlet, a control switch set is arranged on the end face of each syringe body, the air inlets are connected with a fan through air inlet tubes, each liquid outlet is fixedly connected with a liquid outlet tube, a needle can sleeve the outer wall of each liquid outlet tube, one end of the fan is arranged on a frame,the bottom of the frame is provided with rotary wheels, the end face of one end of the frame is provided with a plurality of clamp rings, the end face of the frame is provided with a control panel, and the control panel is electrically connected with the control switch set and the fan. The pneumatic syringe has the advantages that air suction and air discharge can be achieved by the fan so as to allow the syringe to complete suction and injection, repeated injection can be performed by a user conveniently by the multiple syringe bodies, work efficiency is increased, and problems in the prior art are solved effectively.

A connector mountable to a syringe barrel has a proximal barrel-engaging portion, a distal luer fitment portion, and a fluid aperture therethrough. The barrel-engaging portion of the connector includes an axial ledge configured to abut the axial distal edge of a glass syringe barrel. The connector facilitates mounting a luer assembly to the barrel. The luer assembly may be a tip cap having a complementary luer fitment for connection to the luer fitment portion of the connector. The luer assembly may be a luer needle assembly having a complementary luer fitment for connection to the luer fitment portion of the connector. The connector and syringe may further include an immobile, compressible needle seal. The needle seal is adjacent to or engageable with the barrel-engaging portion of the connector. The syringe may be configured with a plunger capable of engaging a retractable needle.